
TY  - JOUR
AU  - Hatzichristou, D.
AU  - Wespes, E.
TI  - P-04 Pharmacology
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_4.x
DO  - doi:10.1111/j.1743-6109.2007.00390_4.x
SP  - 114
EP  - 117
PY  - 2007
ER  - 

TY  - JOUR
AU  - Chen, J.
AU  - Arver, S.
TI  - P-05 Ejaculatory Disorders
JO  - The Journal of Sexual Medicine
VL  - 4
IS  - s2
SN  - 1743-6095
UR  - https://doi.org/10.1111/j.1743-6109.2007.00390_5.x
DO  - doi:10.1111/j.1743-6109.2007.00390_5.x
SP  - 118
EP  - 121
PY  - 2007
ER  - 

TY  - JOUR
TI  - Poster session 1: Apheresis
JO  - Vox Sanguinis
VL  - 95
IS  - s1
SN  - 0042-9007
UR  - https://doi.org/10.1111/j.1423-0410.2008.01056.x
DO  - doi:10.1111/j.1423-0410.2008.01056.x
SP  - 74
EP  - 326
PY  - 2008
ER  - 

TY  - JOUR
AU  - ISRAELS, S. J.
AU  - EL-EKIABY, M.
AU  - QUIROGA, T.
AU  - MEZZANO, D.
TI  - Inherited disorders of platelet function and challenges to diagnosis of mucocutaneous bleeding
JO  - Haemophilia
VL  - 16
IS  - s5
SN  - 1351-8216
UR  - https://doi.org/10.1111/j.1365-2516.2010.02314.x
DO  - doi:10.1111/j.1365-2516.2010.02314.x
SP  - 152
EP  - 159
KW  - Glanzmann thrombasthenia
KW  - haemostasis
KW  - mucocutaneous bleeding
KW  - platelet disorders
KW  - platelet function tests
PY  - 2010
AB  - Summary.? Platelets play a pivotal role in the arrest of bleeding at sites of vascular injury. Following endothelial damage, they respond rapidly by adhesion to subendothelial matrix proteins resulting in platelet activation, spreading, aggregation, secretion and recruitment of additional platelets to form the primary haemostatic plug. This mass provides a surface for thrombin generation and fibrin mesh formation that stabilizes the clot. Careful study of patients with inherited platelet disorders and, subsequently, of informative animal models, has identified structural platelet abnormalities that have enhanced our understanding of platelet function. The investigations of rare, but severe, inherited platelet disorders have led us to the discovery of causative molecular defects. One of the most informative is the rare autosomal recessive disorder Glanzmann thrombasthenia, caused by defect or deficiency in the platelet integrin αIIb?3, resulting in absent platelet aggregation and a significant clinical bleeding diathesis. Our new challenge is to understand the mechanisms underlying more common, but less well-defined, mucocutaneous bleeding (MCB) disorders. Present diagnostic testing for platelet function disorders and von Willebrand?s Disease often fails to identify the cause of bleeding in individuals with inherited MCB.
ER  - 

TY  - JOUR
TI  - Proceedings of the Thrombosis and Hemostasis summit of North America: Research abstracts
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 87
IS  - S1
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.23168
DO  - doi:10.1002/ajh.23168
SP  - S146
EP  - S200
PY  - 2012
ER  - 

TY  - JOUR
TI  - Research Communications of the 26th ECVIM-CA Congress
JO  - Journal of Veterinary Internal Medicine
JA  - J Vet Intern Med
VL  - 31
IS  - 1
SN  - 0891-6640
UR  - https://doi.org/10.1111/jvim.14600
DO  - doi:10.1111/jvim.14600
SP  - 186
EP  - 270
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstract
JO  - Journal of Thrombosis and Haemostasis
JA  - Journal of Thrombosis and Haemostasis
VL  - 5
IS  - S2
SN  - 1538-7933
UR  - https://doi.org/10.1111/j.1538-7836.2007.tb00027.x
DO  - doi:10.1111/j.1538-7836.2007.tb00027.x
SP  - P-T-001
EP  - P-T-200
PY  - 2007
ER  - 

TY  - JOUR
AU  - Mar, Nataliya
AU  - Gorgan, Maria A.
AU  - Dailey, Mark E.
AU  - Vredenburgh, James J.
TI  - Blue toes and a new pair of shoes—Challenges in diagnosis and treatment of acute myelogenous leukemia
JO  - American Journal of Hematology
JA  - Am. J. Hematol.
VL  - 88
IS  - 12
SN  - 0361-8609
UR  - https://doi.org/10.1002/ajh.23563
DO  - doi:10.1002/ajh.23563
SP  - 1090
EP  - 1093
PY  - 2013
ER  - 

TY  - JOUR
TI  - Abstracts presented at the 52nd Annual Meeting of the American Society of Dermatopathology
JO  - Journal of Cutaneous Pathology
JA  - J Cutan Pathol
VL  - 43
IS  - 1
SN  - 0303-6987
UR  - https://doi.org/10.1111/cup.12663
DO  - doi:10.1111/cup.12663
SP  - e1
EP  - e139
PY  - 2016
ER  - 

TY  - JOUR
AU  - RODRIGUEZ-MERCHAN, E. C.
AU  - JIMENEZ-YUSTE, V.
AU  - AZNAR, J. A.
AU  - HEDNER, U.
AU  - KNOBE, K.
AU  - LEE, C. A.
AU  - LJUNG, R.
AU  - QUEROL, F.
AU  - SANTAGOSTINO, E.
AU  - VALENTINO, L. A.
AU  - CAFFARINI, A.
TI  - Joint protection in haemophilia
JO  - Haemophilia
VL  - 17
IS  - s2
SN  - 1351-8216
UR  - https://doi.org/10.1111/j.1365-2516.2011.02615.x
DO  - doi:10.1111/j.1365-2516.2011.02615.x
SP  - 1
EP  - 23
KW  - haemarthrosis
KW  - haemophilia
KW  - inhibitor
KW  - joint
KW  - prophylaxis
KW  - protection
PY  - 2011
AB  - Summary.? Haemarthroses (intra-articular haemorrhages) are a frequent finding typically observed in patients with haemophilia. Diagnosis and treatment of these bleeding episodes must be delivered as early as possible. Additionally, treatment should ideally be administered intensively (enhanced on-demand treatment) until the resolution of symptoms. Joint aspiration plays an important role in acute and profuse haemarthroses as the presence of blood in the joint leads to chondrocyte apoptosis and chronic synovitis, which will eventually result in joint degeneration (haemophilic arthropathy). Ultrasonography (US) is an appropriate diagnostic technique to assess the evolution of acute haemarthrosis in haemophilia, although magnetic resonance imaging remains the gold standard as far as imaging techniques are concerned. Some patients experience subclinical haemarthroses, which eventually tend to result in some degree of arthropathy, especially in the ankles. Nowadays, the most effective way of protecting these patients is primary prophylaxis, which in practice changes severe haemophilia into moderate haemophilia, preventing or at least minimizing the occurrence of haemarthrosis. If primary prophylaxis is, for whatever reason not an option, secondary prophylaxis and enhanced on demand treatment should be considered. Two alternatives are available for inhibitor patients: (i) control of haemostasis using by-passing agents (rFVIIa or aPCCs) either as enhanced on demand treatment or secondary prophylaxis, as appropriate, following the same basic principles used for non-inhibitor patients and (ii) immune tolerance induction (ITI) to eradicate the inhibitor.
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Anaesthesia
JA  - Anaesthesia
VL  - 72
IS  - S3
SN  - 0003-2409
UR  - https://doi.org/10.1111/anae.13974
DO  - doi:10.1111/anae.13974
SP  - 11
EP  - 106
PY  - 2017
ER  - 

TY  - JOUR
AU  - Bowman, Barbara H.
AU  - Yang, Funmei
AU  - Adrian, Gwendolyn S.
TI  - Expression of human plasma protein genes in ageing transgenic mice
JO  - BioEssays
JA  - Bioessays
VL  - 12
IS  - 7
SN  - 0265-9247
UR  - https://doi.org/10.1002/bies.950120703
DO  - doi:10.1002/bies.950120703
SP  - 317
EP  - 322
PY  - 1990
AB  - Abstract Introduction of human plasma protein genes into the mouse genome to produce transgenic mice furnishes an in vivo model for correlating chromosomal DNA sequences with developmental and tissue-specific expression. The liver produces an array of plasma proteins that circulate throughout the body contributing to homeostasis. Non-hepatic tissue sites of synthesis have been identified where a local provision of plasma proteins in needed. Analysis of expression of human plasma protein genes in ageing transgenic mice appears especialy promising in identifying DNA sequences that respond to environmental adversities such as inflammatory factors, hormonal changes and metal toxicity. The results indicate that human genes encoding and controlling liver plasma proteins serve as useful models for studying genetic regulation in the background of development and ageing.
ER  - 

TY  - JOUR
TI  - Free Communications
JO  - British Journal of Haematology
VL  - 129
IS  - s1
SN  - 0007-1048
UR  - https://doi.org/10.1111/j.1365-2141.2005.05435.x
DO  - doi:10.1111/j.1365-2141.2005.05435.x
SP  - 1
EP  - 83
PY  - 2005
ER  - 

TY  - JOUR
TI  - Abstracts - Poster Presentations
JO  - Transfusion Medicine
VL  - 19
IS  - s1
SN  - 0958-7578
UR  - https://doi.org/10.1111/j.1365-3148.2009.00955.x
DO  - doi:10.1111/j.1365-3148.2009.00955.x
SP  - 20
EP  - 43
PY  - 2009
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - The FEBS Journal
VL  - 273
IS  - s1
SN  - 1742-464X
UR  - https://doi.org/10.1111/j.1742-4658.2006.05277.x
DO  - doi:10.1111/j.1742-4658.2006.05277.x
SP  - 77
EP  - 367
PY  - 2006
ER  - 

C7  - pp. 608-628
TI  - Index
SN  - 9781405122023
UR  - https://doi.org/10.1002/9780470987094.index
DO  - doi:10.1002/9780470987094.index
SP  - 608-628
PY  - 2006
ER  - 

C7  - pp. 57-553
TI  - Drug monographs
SN  - 9781118819593
UR  - https://doi.org/10.1002/9781118819494.ch15
DO  - doi:10.1002/9781118819494.ch15
SP  - 57-553
PY  - 2006
ER  - 

TY  - JOUR
TI  - Miscellaneous Liver Disease
JO  - HPB
VL  - 7
IS  - S1
SN  - 9781118819593
UR  - https://doi.org/10.1080/16515320510036895
DO  - doi:10.1080/16515320510036895
SP  - 37
EP  - 46
PY  - 2005
ER  - 

TY  - JOUR
TI  - Special Symposium, “Transplantation in the Hyperimmunized Patient”
JO  - Xenotransplantation
VL  - 16
IS  - 5
SN  - 9781118819593
UR  - https://doi.org/10.1111/j.1399-3089.2009.00539_3.x
DO  - doi:10.1111/j.1399-3089.2009.00539_3.x
SP  - 329
EP  - 389
PY  - 2009
ER  - 

TY  - JOUR
TI  - 2013 Annual Meeting Abstract Supplement
JO  - Arthritis & Rheumatism
JA  - Arthritis & Rheumatism
VL  - 65
IS  - S10
SN  - 9781118819593
UR  - https://doi.org/10.1002/art.38216
DO  - doi:10.1002/art.38216
SP  - S1
EP  - S1331
PY  - 2013
ER  - 
